862270-94-8 Usage
Uses
Used in Pharmaceutical Industry:
2,3-Quinoxalinedione, 1,4-dihydro-5-hydroxyis used as a potential antihypertensive agent for its ability to lower blood pressure. Its vasodilator properties help in relaxing blood vessels, improving blood flow, and reducing the workload on the heart.
2,3-Quinoxalinedione, 1,4-dihydro-5-hydroxyis also used as a potential antineoplastic agent for its ability to inhibit the growth and proliferation of cancer cells. Its antineoplastic activity makes it a promising candidate for the development of new drugs to treat various types of cancer.
Furthermore, 2,3-Quinoxalinedione, 1,4-dihydro-5-hydroxyis used as a potential anti-inflammatory agent for its ability to reduce inflammation and alleviate pain. Its anti-inflammatory properties can be beneficial in the treatment of various inflammatory conditions.
In addition to these applications, 2,3-Quinoxalinedione, 1,4-dihydro-5-hydroxymay also have potential applications in the development of new drugs for the treatment of other medical conditions, given its unique structure and properties. Further research and development are needed to fully explore its therapeutic potential and optimize its use in various medical applications.
Check Digit Verification of cas no
The CAS Registry Mumber 862270-94-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,2,2,7 and 0 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 862270-94:
(8*8)+(7*6)+(6*2)+(5*2)+(4*7)+(3*0)+(2*9)+(1*4)=178
178 % 10 = 8
So 862270-94-8 is a valid CAS Registry Number.
862270-94-8Relevant academic research and scientific papers
QUINOXALINEDIONE DERIVATIVES
-
Page/Page column 34, (2010/01/12)
The present invention relates to compounds of formula (I) wherein X, Y, Z, R1, R2, R3 are as defined in claim 1, including pharmaceutical compositions thereof and for their use in the treatment and/or prevention of diabete
VANILLOID RECEPTOR LIGANDS AND THEIR USE IN TREATMENTS
-
Page/Page column 29, (2008/06/13)
Pyrimidine ethers and compositions containing them, for the treatment of acute, inflammatory and neuropathic pain, dental pain, general headache, migraine, cluster headache, mixed-vascular and non-vascular syndromes, tension headache, general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, inflammatory pain and associated hyperalgesia and allodynia, neuropathic pain and associated hyperalgesia and allodynia, diabetic neuropathy pain, causalgia, sympathetically maintained pain, deafferentation syndromes, asthma, epithelial tissue damage or dysfunction, herpes simplex, disturbances of visceral motility at respiratory, genitourinary, gastrointestinal or vascular regions, wounds, burns, allergic skin reactions, pruritus, vitiligo, general gastrointestinal disorders, gastric ulceration, duodenal ulcers, diarrhea, gastric lesions induced by necrotising agents, hair growth, vasomotor or allergic rhinitis, bronchial disorders or bladder disorders.
